使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主
Operator
Operator
Hello, and welcome to AMN Healthcare fourth-quarter 2024 earnings call. (Operator Instructions)
各位好,歡迎參加 AMN Healthcare 2024 年第四季財報電話會議。(接線員指示)
I would now like to turn the conference over to Randy. Sir, you may begin.
現在我想把會議交給 Randy。先生,您可以開始了。
Randle Reece - Investor Relations
Randle Reece - Investor Relations
Good afternoon, everyone. Welcome to AMN Healthcare's fourth quarter and full-year 2024 earnings call. A replay of this webcast will be available at ir.amnhealthcare.com at the conclusion of this call.
各位下午好。歡迎參加 AMN Healthcare 2024 年第四季及全年財報電話會議。本次網路直播的重播將於本次電話會議結束後,於 ir.amnhealthcare.com 提供。
Remarks we make during this call about future expectations, projections, trends, plans, events, or circumstances constitute forward-looking statements. These statements reflect the company's current beliefs based upon information currently available to it. Our actual results may differ materially from those indicated by these forward-looking statements, because of various factors and cautionary statements, including those identified in our most recently filed forms 10-K and 10-Q, our earnings release, and subsequent filings with the SEC.
我們在本次電話會議中就未來預期、預測、趨勢、計畫、事件或情況所作的評論,均構成前瞻性陳述。這些陳述反映公司基於目前可得資訊所持有的當前信念。由於各種因素及警示性陳述(包括我們最近提交的 10-K 與 10-Q 表格、財報新聞稿以及其後向 SEC 提交的文件中所識別者),我們的實際結果可能與這些前瞻性陳述所示者存在重大差異。
The company does not intend to update guidance or any forward-looking statements provided today prior to its next earnings release. This call contains certain non-GAAP financial information. Information regarding and reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are included in our earnings release and on our financial reports page at ir.amnhealthcare.com.
公司無意在下一次財報發布前更新今日提供的指引或任何前瞻性陳述。本次電話會議包含若干非 GAAP 財務資訊。有關這些非 GAAP 指標以及其與最直接可比 GAAP 指標之調節資訊,已載於我們的財報新聞稿,並公布於 ir.amnhealthcare.com 的財務報告頁面。
On the call with me today are Cary Grace, President and Chief Executive Officer; and Brian Scott, Chief Financial and Operating Officer. I will now turn the call over to Cary.
今天與我一同出席電話會議的有:總裁兼執行長 Cary Grace,以及財務與營運長 Brian Scott。現在我把電話會議交給 Cary。
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Thank you, Randy, and welcome to our quarterly conference call. We are pleased to report that AMN Healthcare ended 2024 with solid financial results. And that trend has continued as we've started 2025.
謝謝你,Randy,並歡迎各位參加我們的季度電話會議。我們很高興報告,AMN Healthcare 以穩健的財務表現結束 2024 年。而這一趨勢在我們進入 2025 年後仍持續。
Fourth quarter revenue of $735 million was $30 million above the high end of our guidance range. And adjusted EBITDA of $75 million also exceeded the expectations.
第四季營收為 7.35 億美元,較我們指引區間上緣高出 3,000 萬美元。調整後 EBITDA 為 7,500 萬美元,也超出預期。
Our Nurse and Allied Solutions revenue was 6% above the high end of guidance, and this segment still beat by 1%, excluding upside in labor disruption revenue. Physician and Leadership Solutions revenue was on target aided by outperformance from physician permanent placement. Technology and Workforce Solutions revenue was 4% better than guidance, as language services saw improved volume. During the quarter, we repaid $75 million in revolver debt, enabled by another quarter of strong cash flow.
我們的護理與醫事專業(Nurse and Allied Solutions)營收較指引上緣高出 6%;即使排除勞動中斷(labor disruption)營收的上行貢獻,該分部仍高出 1%。醫師與領導力解決方案(Physician and Leadership Solutions)營收符合目標,並受惠於醫師永久安置(permanent placement)表現優於預期。科技與人力解決方案(Technology and Workforce Solutions)營收較指引高出 4%,因語言服務量能改善。本季我們償還了 7,500 萬美元的循環信貸(revolver)債務,得益於又一季強勁的現金流。
Our industry continues to see signs of stabilization. Consistent with last quarter, Travel Nurse orders remain above the April 2024 level, though still 20% below pre-pandemic. These orders typically trend down after November and the drop this year is much less than in the past two years, and in line with pre-pandemic seasonality.
我們的產業持續出現穩定化跡象。與上季一致,旅遊護理(Travel Nurse)訂單仍高於 2024 年 4 月水準,但仍較疫情前低 20%。這些訂單通常在 11 月後走低,而今年的下滑幅度遠小於過去兩年,並與疫情前的季節性一致。
Allied orders grew 7% year over year in the fourth quarter with new orders up 20% year over year. Locum tenens demand was better than normal seasonality, rising 6% from Q3 to Q4. Staffing gross margins declined through 2024, and we are more recently seeing stabilization of margins across our staffing businesses. Unfilled orders and vendor-neutral programs increased again in the fourth quarter as candidates continue to pass over jobs with low pay rates and more staffing firms resist the pressure to accept unprofitable margins.
醫事專業(Allied)訂單在第四季年增 7%,其中新訂單年增 20%。代理醫師(locum tenens)需求優於一般季節性,從第三季到第四季成長 6%。人力派遣毛利率在 2024 年一路下滑,而近期我們看到旗下各派遣業務的毛利率趨於穩定。未填補訂單與中立供應商(vendor-neutral)專案在第四季再度增加,因候選人持續略過低薪職缺,且更多派遣公司抗拒接受無利可圖的毛利壓力。
As 2025 unfolds, macro indicators tell us that after more than two years of stepped-up hiring, the healthcare sector has [erased] the permanent staffing deficit that grew from 2020 to 2022. Wage inflation has remained high, especially for highly qualified professionals. Factors that caused our industry trajectory to detach from labor market fundamentals have eased as Travel Nurse utilization and bill rates have returned to normal levels.
隨著 2025 年展開,總體指標顯示:在超過兩年的加速招募之後,醫療保健產業已[消除] 2020 至 2022 年間擴大的永久人力缺口。薪資通膨仍維持高檔,尤其是對高資歷專業人士。導致本產業走勢與勞動市場基本面脫鉤的因素已趨緩,因旅遊護理使用率與計費費率(bill rates)已回到正常水準。
The next step would be to see client behavior to continue moving towards a renewed focus on long-term objectives for cost-effective flexibility. Hospitals experienced strong growth in patient volume last year and recent analyst survey called for 3% to 4% admissions growth this year.
下一步將是看到客戶行為持續轉向,重新聚焦於以具成本效益的彈性來達成長期目標。醫院去年病患量強勁成長,近期分析師調查預期今年住院人次將成長 3% 至 4%。
To accommodate that volume growth, hospitals grew employment 4% in 2024 and at year-end was 12% higher than the end of 2021 when workforce difficulties were most acute.
為了因應該等量能成長,醫院在 2024 年將員工數增加 4%,至年底時較 2021 年底(當時人力困難最為嚴峻)高出 12%。
Despite tactics to offset labor costs, hospital wage inflation moved back up to 5% in the fourth quarter of 2024. Healthcare organization managed wage pressures last year by reducing average hours worked across their workforce to their lowest levels since 2013.
儘管採取策略以抵銷人力成本,醫院薪資通膨在 2024 年第四季回升至 5%。醫療機構去年透過降低全體員工的平均工時來管理薪資壓力,使平均工時降至 2013 年以來最低水準。
Consistent with that, average hours for travelers also are at a 12-year low, which is negatively impacting the staffing industry's gross margin. In many instances of client needs, we can now demonstrate that Travel Nurses are an attractive alternative to using overtime, to leaving vacant positions open and even to aggressive permanent hiring.
與此一致,旅遊人員的平均工時也處於 12 年來低點,這對人力派遣產業的毛利率造成負面影響。在許多客戶需求情境下,我們現在可以證明:旅遊護理人員是加班、長期職缺空缺,甚至激進永久招募的具吸引力替代方案。
As Travel Nurse staffing was 30% of our 2024 revenue, any demand recovery in this specialty would boost our efforts to return to growth.
由於旅遊護理派遣占我們 2024 年營收的 30%,該專科需求的任何復甦都將推動我們重返成長的努力。
Since our last report, we have continued to see stable bill rates for Nurse and Allied staffing, and bill rates have continued to rise in locum tenens. For the Nurse and Allied segment, our first quarter outlook assumes volume down in the low single digits compared with the fourth quarter average, driven by expected lower international nurse assignments due to VISTA retrogression, and lower utilization by a few of our large clients, mostly offset by growth in other MSP clients and direct and third-party channels.
自上次報告以來,我們持續看到護理與醫事專業派遣的計費費率保持穩定,而代理醫師的計費費率則持續上升。就護理與醫事專業分部而言,我們對第一季的展望假設:相較第四季平均水準,量能將呈低個位數下滑,主要受 VISTA retrogression 導致的國際護理派遣預期下降,以及少數大型客戶使用率降低所影響;但其他 MSP 客戶,以及直客與第三方通路的成長可在很大程度上抵銷上述影響。
For Physician and Leadership Solutions, we expect first quarter revenue to be down slightly from the prior quarter.
就醫師與領導力解決方案而言,我們預期第一季營收將較前一季小幅下降。
Our Technology and Workforce Solutions outlook for the first quarter assumes a low single-digit dip compared with Q4 due to lower VMS volume with language services and outsourced solutions modestly up. Language services achieved our highest minutes delivered in Q4 and we expect to continue that trend in Q1.
我們對第一季科技與人力解決方案的展望假設:相較第四季將出現低個位數下滑,原因是語言服務的 VMS 量能較低,而語言服務與外包解決方案則小幅上升。語言服務在第四季達到我們交付分鐘數的歷史新高,我們預期在第一季將延續該趨勢。
As the healthcare industry seeks long-term solutions for its workforce needs, the AMN team is united behind our mission of innovation and service to health care professionals and the diverse organizations that provide care for millions of Americans. Clinicians and clients have made their voices clear. They want more choices, more visibility and more control.
隨著醫療保健產業尋求其人力需求的長期解方,AMN 團隊團結一致,致力於我們對醫療專業人員以及為數以百萬計美國人提供照護之多元組織的創新與服務使命。臨床人員與客戶已清楚表達他們的聲音。他們希望有更多選擇、更高透明度與更強掌控力。
We are uniquely positioned to provide information-rich technology tools they give clients and health care professionals what they need now. In 2024, we launched and scaled best-in-class technology solutions that provide unprecedented visibility, cost control, mobility and efficiency and staffing management. By the end of the year, we had successfully rolled out our next-generation VMS, ShiftWise Flex, to almost all our ShiftWise users.
我們具備獨特優勢,能提供資訊豐富的科技工具,讓客戶與醫療專業人員取得他們當下所需的一切。在 2024 年,我們推出並擴大部署同級最佳的科技解決方案,提供前所未有的可視性、成本控管、流動性、效率與派遣管理能力。至年底,我們已成功將下一代 VMS——ShiftWise Flex——推廣至幾乎所有 ShiftWise 使用者。
With its ease of use, automation of key functions, support for clinical and nonclinical roles, data-packed market pricing surveillance, internal resource pool management and more, ShiftWise Flex is poised to attract new clients in 2025 and beyond. Our market-leading app for healthcare professionals, Passport, now enables clinicians to store their preferences and enabled by AI automatically apply for matching opportunities, a powerful advantage in competing for the most attractive position.
憑藉其易用性、關鍵功能自動化、對臨床與非臨床角色的支援、資料豐富的市場定價監測、內部資源池管理等功能,ShiftWise Flex 有望在 2025 年及未來吸引新客戶。我們面向醫療專業人員、具市場領先地位的 App——Passport——如今可讓臨床人員儲存其偏好,並在 AI 支援下自動申請相符機會,這是在競逐最具吸引力職位時的一項強大優勢。
Passport also supports locum tenens for the first time. We rolled out our next-generation in-person interpreter scheduling system in our language services business, enabling convenience scheduling by location and language, broadening the capabilities of our interpretation platform. And we have raised the bar higher with WorkWise, which integrates our demand forecasting, staffing and sourcing predictive scheduling and workforce management solutions into a powerful platform.
Passport 也首次支援代理醫師(locum tenens)。我們在語言服務業務中推出下一代現場口譯員排班系統,可依地點與語言進行便利排程,擴展我們口譯平台的能力。此外,我們透過 WorkWise 將門檻再提高:WorkWise 把我們的需求預測、派遣與招募的預測式排程,以及人力管理解決方案整合為一個強大的平台。
Clients are increasingly looking for integrated technology solutions, and we are very pleased with the reception WorkWise has received from current and prospective clients. The recently launched event management capabilities of WorkWise have made AMN a more effective partner supporting clients during labor disruption events where our scale and financial strength are also advantages.
客戶日益尋求整合式科技解決方案,我們對 WorkWise 在現有與潛在客戶間所獲得的回響感到非常滿意。WorkWise 近期推出的事件管理功能,使 AMN 在支援客戶應對勞動中斷事件時成為更有效的合作夥伴,而我們的規模與財務實力亦是優勢。
Technology innovations and operational scale drive our strategy to embrace all parts of our $41 billion addressable market, enabling us to expand service offerings and capture share, not just in our MSPs but also in the direct and third-party channels.
技術創新與營運規模推動我們的策略,讓我們能夠涵蓋我們可觸及市場(TAM)410億美元的各個部分,使我們得以擴大服務內容並提升市占,不僅在我們的MSP業務中,也包括直營與第三方通路。
Our Allied business has improved its direct market fill rates in recent months. Our locum's MSP volume is on an uptrend, which is being reinforced by the addition of locum's support to ShiftWise Flex.
我們的Allied業務在近幾個月提升了其直營市場的補缺率(fill rates)。我們的代班(locum)MSP量呈上升趨勢,並因將代班支援加入ShiftWise Flex而進一步強化。
In summary, AMN has evolved in many ways to identify and focus on the changing needs of clients and health care professionals. Though we provide 18 different solutions to thousands of clients, we work as One AMN, one highly flexible organization capable of delivering AMN service and value in a form that is customized to each client's unique situation.
總結而言,AMN已在多方面演進,以辨識並聚焦於客戶與醫療專業人員不斷變化的需求。儘管我們為數千家客戶提供18種不同的解決方案,我們仍以「One AMN」的方式運作——一個高度彈性的組織,能以符合每位客戶獨特情境的客製化形式,交付AMN的服務與價值。
We have changed the way we operate, making it easier for clients to access our full range of solutions and easier for clinicians to access a broader set of opportunities. The more we enable client success in workforce management, the more AMN will be differentiated in the marketplace. We expect our client-centric strategy to get stronger over time, building long-term value for all our stakeholders. Now I'm thrilled to reintroduce Brian Scott, who will add his perspective on our results and outlook.
我們已改變營運方式,讓客戶更容易取得我們完整的解決方案組合,也讓臨床人員更容易接觸更廣泛的機會。我們越能促進客戶在人力管理上的成功,AMN在市場上的差異化就越明顯。我們預期以客戶為中心的策略將隨時間更為強健,為所有利害關係人建立長期價值。現在我很高興再次介紹Brian Scott,他將分享對我們業績與展望的觀點。
Brian Scott - Chief Financial Officer & Chief Operating Officer
Brian Scott - Chief Financial Officer & Chief Operating Officer
Thank you, Cary, and good afternoon, everyone. Let me start by saying how honored I am to be back at AMN. Although I'm still getting caught up on the changes in the organization and industry, it didn't take long for me to see that this team still has the same passion and values and is energized about our future. AMN has clearly made meaningful progress aligning under a unified go-to-market strategy using technology as a differentiated enabler and improving our operational efficiency with speed to placement that is 33% faster than in 2019.
謝謝你,Cary,各位下午好。我先說,我很榮幸能回到AMN。雖然我仍在追上組織與產業的變化,但我很快就看出這個團隊依然保有同樣的熱情與價值觀,並對我們的未來充滿動能。AMN顯然已取得實質進展:在統一的市場進入(go-to-market)策略下對齊,將科技作為差異化的推動要素,並提升營運效率,使得媒合到任(speed to placement)較2019年快了33%。
However, we know there is still more opportunity to consistently use automation and process changes to drive speed and efficiency across our services, and we have the talent and strategy to make this happen. These efforts will underpin our ability to drive sustained growth and profitability to deliver value to our customers and shareholders. Cary and I look forward to providing future updates on our progress.
然而,我們也知道仍有更多機會可透過自動化與流程變革,持續提升各項服務的速度與效率,而我們具備人才與策略來實現這一點。這些努力將支撐我們推動持續成長與獲利能力,為客戶與股東創造價值。Cary和我期待在未來就我們的進展提供更新。
Turning now to our results. Fourth quarter consolidated revenue was $735 million, above the high end of guidance and consensus driven primarily by higher-than-expected labor disruption revenue in the Nurse and Allied segment.
接著談我們的業績。第四季合併營收為7.35億美元,高於財測區間上緣與市場共識,主要由護理與醫事專業(Nurse and Allied)部門高於預期的勞動中斷(labor disruption)營收所帶動。
Revenue was down 10% from the prior year and up 7% sequentially. Consolidated gross margin for the fourth quarter was 29.8% at the high end of our guidance range. Year over year, gross margin decreased 210 basis points, driven by lower margins across all three segments, partly offset by a favorable segment mix shift.
營收較去年同期下降10%,較前一季成長7%。第四季合併毛利率為29.8%,位於我們財測區間上緣。年對年而言,毛利率下降210個基點,原因是三個部門的毛利率皆下滑,部分被有利的部門組合變動所抵銷。
Sequentially, gross margin was down 120 basis points due to lower margin in the Nurse and Allied segment as well as an unfavorable segment mix shift.
就季對季而言,毛利率下降120個基點,原因是護理與醫事專業部門毛利率較低,以及不利的部門組合變動。
Consolidated SG&A expenses were $159 million, or 21.6% of revenue compared with $185 million, or 22.7% of revenue in the prior year, and $150 million or 21.8% of revenue in the previous quarter. Adjusted SG&A, which excludes certain expenses, was $145 million in the fourth quarter or 19.8% of revenue compared with $159 million or 19.4% of revenue in the prior year period, and $141 million or 20.5% of revenue in the previous quarter. The year-over-year decline in SG&A expenses reflected our efforts to reduce expenses, along with a lower revenue.
合併銷售、一般及行政(SG&A)費用為1.59億美元,占營收21.6%;相較去年同期為1.85億美元、占營收22.7%,以及前一季為1.50億美元、占營收21.8%。調整後SG&A(排除特定費用)在第四季為1.45億美元,占營收19.8%;相較去年同期為1.59億美元、占營收19.4%,以及前一季為1.41億美元、占營收20.5%。SG&A費用年對年下降,反映我們降低費用的努力,以及營收較低。
The quarter-over-quarter increase was driven primarily by unfavorable accruals from a state sales tax audit and professional liability, along with labor disruption support costs, partially offset by cost reduction efforts.
季對季增加主要由不利的應計項目所致,包括州銷售稅稽核與專業責任(professional liability),以及勞動中斷支援成本;部分被成本削減措施所抵銷。
Fourth quarter Nurse and Allied revenue was $455 million, down 15% from the prior year, primarily from lower volume and rates, partially offset by an increase in labor disruption revenue. Sequentially, segment revenue was up 14% as fourth quarter labor disruption revenue more than offset lower volume in Travel Nurse. The Nurse and Allied average bill rate was down 6% year over year and was flat sequentially.
第四季護理與醫事專業營收為4.55億美元,較去年同期下降15%,主要因量與價格下降,部分被勞動中斷營收增加所抵銷。季對季而言,部門營收成長14%,因第四季勞動中斷營收足以抵銷旅遊護理(Travel Nurse)量的下降。護理與醫事專業平均帳單費率(average bill rate)年對年下降6%,季對季持平。
Year-over-year segment volume decreased 22% and average hours worked was down 1%. Sequentially, volume was flat, while average hours work was down 2%.
部門量年對年下降22%,平均工時下降1%。季對季而言,量持平,而平均工時下降2%。
Travel Nurse revenue in the fourth quarter was [$230 million], a decrease of 35% from the prior year period and 6% from the prior quarter. Allied revenue in the quarter was $149 million, down 9% year over year and up 6% sequentially. Nurse and Allied gross margin in the fourth quarter was 23.8%, a decrease of 170 basis points year over year and 120 basis points sequentially primarily due to the decline in international nurse revenue.
第四季旅遊護理營收為[2.30億美元],較去年同期下降35%,較前一季下降6%。本季Allied營收為1.49億美元,年對年下降9%,季對季成長6%。第四季護理與醫事專業毛利率為23.8%,年對年下降170個基點、季對季下降120個基點,主要因國際護理營收下滑。
Segment operating margin of 8.6% decreased 310 basis points year over year and 20 basis points sequentially. The year-over-year decline was mainly due to lower gross margin increased bad debt expense and negative operating leverage.
部門營業利益率為8.6%,年對年下降310個基點,季對季下降20個基點。年對年下降主要因毛利率較低、壞帳費用增加,以及不利的營運槓桿。
Moving to Physician and Leadership Solutions segment. Fourth quarter revenue of $173 million increased 3% year-over-year with the growth coming from the MSDR acquisition. Sequentially, revenue was down 4%, driven primarily by lower volume within the locums and interim businesses.
接著看醫師與領導力解決方案(Physician and Leadership Solutions)部門。第四季營收為1.73億美元,年對年成長3%,成長主要來自MSDR併購。季對季營收下降4%,主要因代班(locums)與臨時管理(interim)業務量較低。
Locum tenens revenue in the quarter was $137 million, up 10% year-over-year, driven by the MSDR acquisition. Sequentially, [revenue is] down 4%, in line with normal seasonality. Interim leadership revenue of $26 million decreased 11% from the prior year period and 9% sequentially due to lower volume and rate. Search revenue of $10 million was down 32% year-over-year and up 2% sequentially.
本季代班醫師(locum tenens)營收為1.37億美元,年對年成長10%,由MSDR併購所帶動。季對季[營收]下降4%,符合正常季節性。臨時領導力(interim leadership)營收為2,600萬美元,較去年同期下降11%,季對季下降9%,因量與費率較低。搜尋(Search)營收為1,000萬美元,年對年下降32%,季對季成長2%。
Gross margin for the Physician and Leadership Solutions segment was 28.5%, down 480 basis points year-over-year, primarily attributable to a lower bill pay spread in locum tenens and an unfavorable revenue mix shift.
醫師與領導力解決方案部門毛利率為28.5%,年對年下降480個基點,主要歸因於代班醫師業務的帳單與薪酬價差(bill pay spread)縮小,以及不利的營收組合變動。
Sequentially, gross margin increased 20 basis points. Segment operating margin was 9.8%, which decreased 320 basis points year over year, primarily due to the lower gross margin and the negative professional liability actuarial adjustment, partially offset by lower employee expenses and lower bad debt. Sequentially, operating margin decreased 20 basis points.
季對季而言,毛利率增加20個基點。部門營業利益率為9.8%,年對年下降320個基點,主要因毛利率較低以及不利的專業責任精算調整(actuarial adjustment);部分被員工費用較低與壞帳較低所抵銷。季對季而言,營業利益率下降20個基點。
Technology and Workforce Solutions revenue for the fourth quarter was $107 million, down 5% year over year as growth in language services was more than offset by decreases in VMS and outsourced solutions. Sequentially, revenue was down 1%.
第四季科技與人力解決方案(Technology and Workforce Solutions)營收為1.07億美元,年對年下降5%;語言服務的成長被VMS與外包解決方案的下滑所抵銷。季對季營收下降1%。
Language services revenue for the quarter was $76 million, an increase of 12% year over year and 2% sequentially. VMS revenue for the quarter was $23 million, a decrease of 26% year over year and 10% sequentially. Segment gross margin was 57.3%, down 320 basis points from the prior year period, primarily due to the lower mix of VMS and outsourced solutions revenue, partially offset by margin improvements within language services.
本季語言服務營收為7,600萬美元,年對年成長12%,季對季成長2%。本季VMS營收為2,300萬美元,年對年下降26%,季對季下降10%。部門毛利率為57.3%,較去年同期下降320個基點,主要因VMS與外包解決方案營收占比降低;部分被語言服務的毛利率改善所抵銷。
Sequentially, gross margin declined 60 basis points, mainly due to a revenue mix shift. Segment operating margin in the fourth quarter was 37.7%, an increase of 90 basis points from the prior year period, driven primarily by expense management, partially offset by the lower gross margin.
季對季而言,毛利率下降60個基點,主要因營收組合變動。第四季部門營業利益率為37.7%,較去年同期增加90個基點,主要由費用管理所帶動,部分被較低的毛利率所抵銷。
Sequentially, the operating margin declined by 130 basis points on the lower gross margin and increased bad debt expense. Fourth quarter consolidated adjusted EBITDA was $75 million, down 20% year over year and up 2% sequentially. Adjusted EBITDA margin for the quarter of 10.2% was down 250 basis points from the prior year, primarily driven by lower gross margin and negative operating leverage.
按季而言,由於毛利率較低及壞帳費用增加,營業利益率下滑130個基點。第四季合併調整後EBITDA為7,500萬美元,年減20%,季增2%。本季調整後EBITDA利益率為10.2%,較去年同期下降250個基點,主要受毛利率下降及負向營運槓桿影響。
Sequentially, adjusted EBITDA margin was down 50 basis points due to the lower gross margin, partially offset by expense management. During the fourth quarter, we performed a quantitative impairment test of our goodwill.
按季而言,調整後EBITDA利益率因毛利率較低而下降50個基點,部分被費用管理所抵銷。第四季期間,我們對商譽進行了量化減損測試。
This assessment resulted in a noncash impairment charge of $222 million, impacting the Nurse and Allied and Physician and Leadership Solutions segment. Net interest expense [and other] in the quarter was $23 million, and included a $10 million noncash charge related to the revaluation of minority equity investments.
此評估導致2.22億美元的非現金減損費用,影響護理與聯合醫療(Nurse and Allied)以及醫師與領導力解決方案(Physician and Leadership Solutions)部門。本季淨利息費用[及其他]為2,300萬美元,其中包含與少數股權投資重估相關的1,000萬美元非現金費用。
Fourth quarter net loss was $188 million, driven in large part by the non-cash goodwill impairment charge. This compared with net income of $12.5 million in the prior year and $7 million in the prior quarter.
第四季淨損為1.88億美元,主要由非現金商譽減損費用所致。相較之下,去年同期淨利為1,250萬美元,上一季淨利為700萬美元。
Fourth quarter GAAP diluted loss per share was $4.90. Adjusted earnings per share for the quarter was $0.75 compared with $1.32 in the prior year and $0.61 in the prior quarter. Days sales outstanding for the quarter was 55 days, which was 15 days lower than a year ago.
第四季GAAP稀釋後每股虧損為4.90美元。本季調整後每股盈餘為0.75美元,較去年同期的1.32美元下降,但高於上一季的0.61美元。本季應收帳款週轉天數(DSO)為55天,較一年前減少15天。
Sequentially, DSO improved by five days, in large part due to the upfront payment on labor disruption revenue recognized during the quarter. Operating cash flow in the fourth quarter was $73 million, and capital expenditures were $16 million. As of December 31, we had cash and equivalents of $11 million and long-term debt of $1.06 billion, including $210 million drawn on revolving line of credit.
按季而言,DSO改善5天,主要由於本季認列的勞動中斷收入所收到的預付款。第四季營運現金流為7,300萬美元,資本支出為1,600萬美元。截至12月31日,我們持有現金及約當現金1,100萬美元,長期負債10.6億美元,其中包含循環信用額度已動用2.10億美元。
We ended the year with a net leverage ratio of 3.0x to 1x. With a focus in 2024 on debt reduction, we paid down the revolver by $75 million in the quarter and $250 million for the full year. Recapping financial highlights for the full year 2024, we reported revenue of $3 billion, a year-over-year decrease of 21%.
我們在年底的淨槓桿比率為3.0倍。2024年聚焦於降債,我們本季償還循環額度7,500萬美元,全年合計償還2.50億美元。回顧2024年全年財務重點,我們營收為30億美元,年減21%。
Gross margin for the year was 30.8%, a decrease of 220 basis points from the prior year. Adjusted EBITDA was $341 million, a decrease of 41% from the prior year.
全年毛利率為30.8%,較去年下降220個基點。調整後EBITDA為3.41億美元,較去年下降41%。
Full year adjusted EBITDA margin of 11.4% was 390 basis points lower year over year. For 2024, we reported a GAAP loss per share of $3.85 and adjusted EPS was $3.31 compared with the prior year GAAP EPS of $5.36 and adjusted EPS of $8.21.
全年調整後EBITDA利益率為11.4%,年減390個基點。2024年我們GAAP每股虧損為3.85美元,調整後EPS為3.31美元;相較去年GAAP EPS為5.36美元、調整後EPS為8.21美元。
Full year cash flow from operations was $320 million and capital expenditures totaled $81 million.
全年營運活動現金流為3.20億美元,資本支出合計8,100萬美元。
Moving now to first quarter guidance. We project consolidated revenue to be in the range of $660 million to $680 million, down 17% to 20% in the prior year period. This guidance includes an assumption of $24 million of labor disruption revenue.
接著說明第一季財測。我們預估合併營收介於6.60億至6.80億美元,較去年同期下降17%至20%。此指引包含勞動中斷收入2,400萬美元的假設。
Gross margin is projected to be between 28.1% and 28.6%. Reported SG&A expenses are projected to be 22.2% to 22.7% of revenue. Operating margin is expected to be minus 0.3% to a positive 0.4%, and adjusted EBITDA margin is expected to be 7.7% to 8.2%. Additional first quarter guidance details can be found in today's earnings release.
毛利率預估介於28.1%至28.6%。申報的SG&A費用預估占營收22.2%至22.7%。營業利益率預期為負0.3%至正0.4%,調整後EBITDA利益率預期為7.7%至8.2%。第一季指引的更多細節請參閱今日的財報新聞稿。
For modeling purposes, we anticipate full year capital expenditures of $40 million to $50 million, stock-based compensation expense of $35 million and a non-GAAP tax rate of 26% to 28%.
為便於建模,我們預期全年資本支出為4,000萬至5,000萬美元,股票基礎薪酬費用為3,500萬美元,非GAAP稅率為26%至28%。
Before we open up the call for questions, I will hand the call back to Cary.
在我們開放提問之前,我將把電話交回給Cary。
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Thank you, Brian, and welcome back.
謝謝你,Brian,歡迎回來。
Before I open the call to Q&A, I want to thank Doug Wheat, our long-time Chairman of our Board of Directors, who announced his retirement earlier this month and has become AMN Healthcare's Board Chair Emeritus. Doug provided invaluable leadership and guidance to the company and management over the past 25 years, including helping take the company public 23 years ago. We thank Doug for his service to our organization and welcome Mark Foletta as the new Board Chairman. Mark has deep public company leadership and governance experience, both as a Board member and as a CFO.
在我開放Q&A之前,我想感謝我們董事會長期主席Doug Wheat;他於本月稍早宣布退休,並成為AMN Healthcare董事會榮譽主席(Board Chair Emeritus)。過去25年,Doug為公司與管理團隊提供了無可取代的領導與指導,包括協助公司在23年前上市。我們感謝Doug對本組織的貢獻,並歡迎Mark Foletta擔任新任董事會主席。Mark在上市公司領導與公司治理方面經驗深厚,既擔任過董事會成員,也擔任過CFO。
Now operator, please open the call for questions.
現在請接線員開放提問。
Operator
Operator
(Operator Instructions) Tobey Sommer, Truist.
(接線員指示) Truist的Tobey Sommer。
Jasper Bibb - Analyst
Jasper Bibb - Analyst
It's Jasper Bibb on for Tobey. I wanted to ask about gross margins in Nurse and Allied. How are you thinking about the segment gross margins there in the first quarter, and could you maybe extrapolate for us like how the labor structural revenue might influence that margin versus what otherwise might be comparable to a year ago.
我是代替Tobey的Jasper Bibb。我想請教護理與聯合醫療(Nurse and Allied)的毛利率。你們如何看待該部門第一季的部門毛利率?另外能否幫我們推估一下,勞動結構性收入可能會如何影響該毛利率,相較於在其他條件相同下、與一年前可比的水準?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Josh, there's nothing like a welcome back to Brian than a gross margin question in the first piece. So we'll talk a little bit about -- I think you got the big points that we're seeing. We obviously have a part of it that's mix and particularly coming from headwinds that we have in international that we saw really throughout 2024 that will continue into 2025. So Brian, if you want to maybe give --
Josh,沒有什麼比一開始就問毛利率更能歡迎Brian回歸了。所以我們來談談——我想你已經掌握我們看到的重點。其中一部分顯然是組合因素,特別是來自國際業務的逆風;我們在2024年幾乎全年都看到,並將延續到2025年。所以Brian,如果你願意也許可以補充--
Brian Scott - Chief Financial Officer & Chief Operating Officer
Brian Scott - Chief Financial Officer & Chief Operating Officer
Yes. Thanks, Cary. Jasper, thanks for the question. Yes, there's a few moving parts on the gross margin, as you probably know. Within Nurse and Allied specifically, the margin in the fourth quarter at 23.8% in part, reflected some sales reserve reversals that we took in the fourth quarter that we had talked about on the last quarter.
好的。謝謝,Cary。Jasper,謝謝你的提問。是的,毛利率確實有幾個變動因素,如你所知。就護理與聯合醫療部門而言,第四季23.8%的毛利率部分反映了我們在第四季做的一些銷售準備金回轉,我們在上一季已談到過。
And so that -- if you take that in the context of our Q1 guidance, we would have been closer to, call it, 22.5%. And so our expectation for Q1 is relatively similar to the fourth quarter, and that's the team doing a really good job of looking at pay packages and negotiating. And the trends we're seeing with bill rates stabilizing in the last couple of quarters and expected to be up modestly in the first quarter, we're seeing pretty stable gross margin trends in the Nurse and Allied segment.
因此——若把這點放在我們第一季指引的脈絡下,我們會更接近約22.5%。我們對第一季的預期與第四季相對接近,這要歸功於團隊在檢視薪酬方案與談判方面做得非常好。而我們看到的趨勢是,過去幾季帳單費率(bill rates)已趨於穩定,且預期第一季將小幅上升,因此我們在護理與聯合醫療部門看到相當穩定的毛利率趨勢。
Jasper Bibb - Analyst
Jasper Bibb - Analyst
And then you mentioned, obviously, the normalization of [domain] conditions. In the prepared remarks, bill rate's up a little bit [in] the first quarter. What do you think you need to see in the market to start growing the Nurse and Allied volume sequentially this year?
然後你也提到,顯然,[domain]狀況的正常化。在事先準備的發言中,第一季帳單費率會小幅上升。你認為市場需要出現哪些訊號,才能讓護理與聯合醫療的量在今年按季開始成長?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Yes. I think what we've seen and what we talked about this quarter and last quarter is a number of signs around normalization. And I think they really all speak to different parts of health care systems really getting back into much more of a normal mix between permanent a layer of contingent staff and a layer of flexible staff.
是的。我想我們在本季與上一季談到的是,圍繞正常化出現了多項跡象。而我認為這些跡象都指向醫療體系的不同面向,正在回到更正常的組合:在永久人力之外,有一層臨時(contingent)人力,以及一層彈性人力。
And so we've seen a lot of -- when you look at some of the things that would typically drive buying behavior, normalization of premium. So our estimate today of premium spread over fully loaded labor cost is about 10%, the lower end of what you would have seen historically.
因此我們看到很多——當你觀察一些通常會驅動採購行為的因素時,例如溢價的正常化。我們目前估計,相對於全額負擔的人力成本(fully loaded labor cost),溢價差距約為10%,處於歷史上你通常會看到的較低端水準。
And so what we want to see now, Jasper, is if recent analyst reports are predicting patient demand increasing 3% to 4%, and you still see probably above-average wage inflation in healthcare, you'd want to start seeing some of that play through in terms of orders then getting picked up as we go through the year to reflect some of those tailwinds.
所以我們現在想看到的是,Jasper,如果近期分析師報告預測病患需求將增加3%到4%,而你仍然看到醫療保健領域可能出現高於平均的薪資通膨,那麼你會希望開始看到其中一部分在訂單上反映出來,並在今年推進的過程中逐步被帶動起來,以體現這些順風因素。
Operator
Operator
A.J. Rice, UBS.
A.J. Rice,瑞銀(UBS)。
Albert Rice - Analyst
Albert Rice - Analyst
Just wondering if -- we've got the strike revenue. We've got other things going on in the fourth and first quarter, and then there's seasonality. I'm trying to understand how do you -- do you feel like you're seeing a normal pattern here that was similar to what you would have seen pre-pandemic? Do you feel like there's still some softness. And any early thoughts about how the trajectory of the rest of the year for '25 might play out?
我只是想問一下——我們有罷工帶來的營收。第四季和第一季還有其他事情在發生,另外也有季節性因素。我想了解你們——你們覺得目前看到的是一種正常的型態嗎,類似於疫情前你們會看到的情況?你們覺得是否仍有一些疲軟?以及對於2025年其餘時間的走勢,是否有任何初步想法?
What are you looking for in terms of revenue trends as we progress through the rest of the year?
隨著我們走過今年剩餘時間,你們在營收趨勢方面在尋找什麼?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Let me talk about what we've seen. And then I can tag team with Brian on what we expect. We've seen a more return to normal. If you look at normal being what we would have seen pre-COVID. And so as an example, and I talked about this in some of the opening remarks, we've seen order increases in nursing since last April.
我先談談我們看到的情況。然後我可以和Brian搭配談談我們的預期。我們看到的是更回歸正常。如果把「正常」定義為疫情前我們會看到的狀況。舉例來說,我在開場致詞中也提到,自去年4月以來,我們看到護理(nursing)的訂單增加。
We would normally see from November until now, a drop off of those orders. We saw that. It was actually not as much as we had seen pre-COVID. So you're really starting to see for us more of that return to normal. Locums, you typically see a little bit of seasonality weakness at the end of the year.
通常從11月到現在,我們會看到這些訂單下滑。我們確實看到了。但實際上下滑幅度沒有疫情前那麼大。所以對我們而言,你真的開始看到更多回歸正常。至於臨時醫師(locums),通常在年底會看到一些季節性走弱。
And so we don't have as much visibility as we would ideally like. But what we do have visibility in, we are seeing more normalcy as we enter 2025 than we have seen in the past couple of years.
因此我們的能見度沒有理想中那麼高。但就我們有能見度的部分來看,進入2025年時,我們看到的正常化程度比過去兩年更高。
Brian Scott - Chief Financial Officer & Chief Operating Officer
Brian Scott - Chief Financial Officer & Chief Operating Officer
A.J., it's Brian. Yes, I mean, the fourth quarter, I think, played out overall as expected. We see the labor disruption event went longer than we anticipated, and that added some additional revenue in the fourth quarter and is flowing through into our fourth -- first quarter guidance. If you try to strip that out of both quarters and also take out the kind of $5 million-ish sales reserve reversal that we've talked about, we are looking at a little bit of a decline probably in the -- [ particular ] midpoint of our guidance in Q1, call it, $15 million to $20 million or so. And there's a few pieces there.
A.J.,我是Brian。是的,我的意思是,第四季整體來看大致如預期發展。我們看到勞動中斷事件持續時間比我們預期更長,這在第四季帶來了一些額外營收,並延續到我們第四——第一季的指引中。如果你試著把這個因素從兩個季度都剔除,並且也扣除我們談過的約500萬美元左右的銷售準備回轉(sales reserve reversal),那麼在第一季指引的中位數附近,我們看到可能會有些微下滑,大概是1,500萬到2,000萬美元左右。而這裡面有幾個因素。
I think to Cary's point, I think we're seeing much more normalization. There's still some residual flow-through of some of the changes with client behavior, some runoff from early client exits during '24. But for the most part, as we think about as we're moving into Q1, seeing really good trends in locums. I think overall, we'd expect that business to be flat to slightly up in the first quarter, which is pretty normal for it to be up. We're still working through the MSDR integration, but the booking trends especially over the last few weeks have been really positive, which gives us confidence in the first quarter, but also that we'd expect to see growth in the second quarter and beyond.
我想呼應Cary的觀點,我們看到更明顯的正常化。仍有一些殘餘影響,來自客戶行為變化的延續,以及2024年初期客戶退出所造成的一些自然流失。但大致上,當我們進入第一季時,臨時醫師(locums)的趨勢非常好。整體而言,我們預期該業務在第一季將持平到小幅成長,這對它來說相當正常,通常第一季會略為上升。我們仍在推進MSDR整合,但特別是過去幾週的預訂(booking)趨勢非常正面,這讓我們對第一季更有信心,也預期第二季及之後會看到成長。
Language services continues to grow sequentially -- it grew -- we expect it to grow in Q1 and through the year. International is still a bit of a headwind, right, as we talked about, as we have retrogression continuing, we have about a [$5 million -- $4 million to $5 million] reduction expected sequentially in Q1. And then with the Nurse and Allied business, a little bit of a decline on the nursing side as you see some of the winter orders start to roll off. But underneath that, there's still, I think, a more normal combined behavior due to some of the seasonal impacts that are on there.
語言服務(language services)持續季增——它成長了——我們預期第一季會成長,且全年都會持續成長。國際業務仍然是一個逆風,如我們所談到的,隨著簽證排期倒退(retrogression)持續,我們預期第一季將出現約400萬到500萬美元的季減。至於護理與醫療輔助(Nurse and Allied)業務,護理端會有些微下滑,因為一些冬季訂單開始到期回落。但在此之下,我認為由於季節性影響,你仍會看到更正常的綜合行為表現。
And then with VMS also down a little bit in the first quarter as well, again, more reflective of the market environment and some client losses from '24 that just are kind of working their way through the system. So Q1, I think, sets a really good foundation for 2025, and it's a good marker ex that strike. And as we think about the rest of the year, we did good opportunities for the businesses to grow and a lot of really good momentum in most of our service lines.
另外,VMS在第一季也會小幅下滑,同樣更反映市場環境,以及2024年一些客戶流失正逐步在系統中消化。所以我認為第一季為2025年奠定了非常好的基礎,而且在剔除那次罷工因素後,是一個很好的觀察基準。當我們看今年其餘時間時,我們看到各業務都有不錯的成長機會,而且我們多數服務線都有非常好的動能。
Albert Rice - Analyst
Albert Rice - Analyst
Okay. That's great. Maybe a follow-up, I'll ask. In the prepared remarks, you mentioned and you mentioned a couple of times in answering the international headwind. Do you have a sense of what the international revenue or impact would be EBITDA impact of '24 versus '25 million overall, I'm sure it varies a little bit depending on how demand looks, but I'm just curious if they got a figure there.
好的。很棒。我再追問一下。在事先準備的發言中,你提到、而且在回答國際業務逆風時也提到好幾次。你是否能大致估算一下,國際業務在2024年相較2025年,對營收或對EBITDA的影響總體會是多少(百萬美元)?我知道會因需求狀況而略有不同,但我只是好奇你們是否有一個數字。
And then the other comment was made in the prepared remarks was about large client seemingly stepping back a little bit. Was that because they're doing it themselves, they've changed vendor? Are they having volume issues? What -- maybe flush that out a little more?
另外,在事先準備的發言中還提到一點,似乎有大型客戶稍微退後了一些。那是因為他們改成自己做、或是更換供應商了嗎?還是他們有量的問題?能否——再多說明一下?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Yes. Let me answer the first one. So what we would expect and very similar to what we talked about last quarter is, if you look at our international business, so take full year 2023 before retrogression started, Total revenue in that business was at $225 million. We expect about $100 million revenue headwind between 2024 and 2025. About 60% of that, A.J., would be in 2024.
是的。我先回答第一個。我們的預期、而且與上季談到的非常類似是:如果你看我們的國際業務,以簽證排期倒退(retrogression)開始前的2023年全年為基準,該業務總營收為2.25億美元。我們預期2024年到2025年之間,營收逆風約為1億美元。其中約60%,A.J.,會發生在2024年。
And so we have the remainder of the headwind in 2025, and mostly in the first 2 quarters of 2025. And so we would expect after that, that you would start to see that flatten out in the back half of the year. And then in 2026, you would start to get growth in that business again.
因此其餘的逆風會在2025年出現,而且主要集中在2025年前兩個季度。我們預期之後在下半年你會開始看到影響趨於持平。然後在2026年,該業務將會再次開始成長。
On your question from a client standpoint, we always like to give color about what we're seeing in some of our top clients. And so while we have seen the majority of our largest MSP clients be relatively flat to growing, we still have a couple of large clients that are reducing their TOA. And it really is just a reflection of them getting back into a target mix of permanent and flexible and contingent staff. And isn't necessarily a commentary on changing models. It's just kind of where they are in that process.
至於你關於客戶面的問題,我們一向希望就一些主要客戶的情況提供更多背景。因此,雖然我們看到大多數最大型的MSP客戶大致持平到成長,但仍有少數大型客戶正在降低他們的TOA。這其實只是反映他們正在回到一個目標的人力組合——正職與彈性/臨時(contingent)人力的配置。這不一定是在評論他們更換模式。只是他們在那個調整過程中的階段而已。
Operator
Operator
Jeff Silber, BMO Capital Markets.
Jeff Silber,BMO資本市場(BMO Capital Markets)。
Jeffrey Silber - Analyst
Jeffrey Silber - Analyst
Welcome back, Brian. And actually, let me start with a question for you. I know it's been a few years since you left the company, and I know things have changed a lot in the industry. But from your perspective, what do you think you can do to help the company get back on track?
歡迎回來,Brian。其實我先從問你一個問題開始。我知道你離開公司已經幾年了,也知道產業裡很多事情都改變了。但從你的角度來看,你認為你能做些什麼來幫助公司重回正軌?
Brian Scott - Chief Financial Officer & Chief Operating Officer
Brian Scott - Chief Financial Officer & Chief Operating Officer
Well, thanks. It's good to be back. Well, I think I'd start with this, this team has already done a tremendous amount of work to get this company on track. So I'm here to do what I can to help that, but there's already been a tremendous amount of work laying that foundation.
嗯,謝謝。很高興回來。我想我會先從這點開始:這個團隊已經做了大量工作,讓公司回到正軌。所以我來這裡是盡我所能去協助,但其實已經有非常多工作在打下那個基礎。
As I mentioned in my opening remarks, we've got, I think, a really fantastic team here. a great blend of folks that I've known for years that are still here, but also some really strong new talent that's been infused in the organization, which I think has been good because, as you said, the industry has changed a fair amount.
如同我在開場致詞中提到的,我認為我們這裡有一支非常出色的團隊。這是一個很好的組合:有我認識多年、至今仍在的同仁,也有一些非常強的新人才注入組織。我認為這是好事,因為如你所說,這個產業已經發生了相當大的變化。
But I'm already seeing a lot of really good work, much more of a unified approach towards -- our clients have done it with both branding, but also just the way we operate internally, engage with our clients. And I think that's going to set us up well -- from just a technology point of view, there's been tremendous work that was needed. It was, I think, an acceleration of use of technology and digitization of our industry over the last several years.
但我已經看到很多非常好的成果,對外—我們的客戶在品牌面向上—以及我們內部的運作方式、與客戶互動方式,都更趨於一致、整合的做法。我認為這將讓我們處於有利位置——從科技角度來看,確實有大量必須完成的工作。過去幾年,我認為我們產業在科技使用與數位化方面加速推進。
And so maybe a little bit of catch up here, but the team has done a lot to close that gap, both the things you see externally with Passport and ShiftWise Flex, really, I think, best-in-class solutions there internally with our -- upgrading our [in-tracking] system, our AMN web solution. And then on the back office side, standardizing more of our businesses on a common ERP.
因此可能有一點追趕的成分,但團隊已做了很多來縮小差距,包括你在外部看到的 Passport 與 ShiftWise Flex;我認為這些都是同級最佳的解決方案;以及內部方面,我們也在——升級我們的 [in-tracking] 系統、我們的 AMN 網頁解決方案。另外在後勤(back office)端,讓更多業務標準化、統一到共同的 ERP 系統上。
All of that is going to help us become more efficient, have better speed to market and then also deliver services that really resonate with clients and allow us to listen more. I think, obviously, when I left, we had a larger mix of our business tied to managed service programs. I think that's still a critically important part of the industry and for clients that want that service.
這些都將幫助我們提升效率、加快上市速度(speed to market),並提供真正能引起客戶共鳴的服務,也讓我們能更傾聽客戶。我想很明顯地,當我離開時,我們的業務組合中有較大比例與託管式服務計畫(managed service programs)相關。我認為那仍然是這個產業、以及對需要該服務的客戶而言,極其重要的一部分。
I think we delivered really well. I think we're better positioned now to be able to meet clients that want more of a vendor-neutral or a hybrid solution. and we can kind of walk that walk as well now, and I see that across the organization. So I think we're -- layed a lot of the right foundation this year, it's a year of execution. And we're feeling good that we're going to -- we'll see the kind of the benefits of those investments and our efforts as we move through the year.
我認為我們交付得非常好。我認為我們現在更有能力去滿足那些希望採用更偏供應商中立(vendor-neutral)或混合式(hybrid)解決方案的客戶;而且我們現在也能真正做到「說到做到」,我在整個組織中都看得到這點。所以我認為——我們今年打下了很多正確的基礎,這是一個執行之年。我們也很有信心,隨著今年推進,我們將看到這些投資與努力所帶來的效益。
Jeffrey Silber - Analyst
Jeffrey Silber - Analyst
All right. That's great to hear. Maybe I could just step back and ask a broader question in terms of the overall marketplace. Are you still seeing hospitals trying to reduce their contract labor? I know [Census] is up, and I know they're focused on full-time employment. But I'm just wondering if you're still seeing pressure on that side of the house.
好的。很高興聽到這些。也許我可以退一步,從整體市場的角度問一個更宏觀的問題。你們是否仍看到醫院試圖降低其合約勞動(contract labor)?我知道 [Census] 在上升,也知道他們聚焦於全職雇用。但我只是想了解,你們是否仍看到在這一端的壓力。
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Yes. What I would say is we're still seeing a focus on contract labor. It's not the cost savings lever that it was even a year ago, right, especially as you've seen the premium spread normalize as you've seen broadly utilization come down.
是的。我會說,我們仍看到對合約勞動的關注。但它已不像一年前那樣是主要的節省成本槓桿,對吧?尤其是當你看到溢價差(premium spread)已趨於正常化、整體使用率也普遍下降之後。
Now there are some systems that still are probably above where they want to be or where they were pre-COVID that still need to come down. But I'd say what we're increasingly seeing is the end of they're still focused on that line item, but they're stepping back and looking at their overall workforce and really wanting to have a partner who's going to help them with how they build high-quality, cost-effective workforces to meet what they see as kind of increasing patient demand.
現在仍有一些醫療體系可能高於他們希望的水準,或高於 COVID 之前的水準,仍需要再降下來。但我想我們越來越看到的是:他們仍關注那個費用科目(line item),但同時也會退一步檢視整體人力結構,並真正希望有一個合作夥伴能協助他們,如何建立高品質、具成本效益的人力隊伍,以因應他們所看到的、某種程度上持續增加的病患需求。
So yes, we're focused on it. they're increasingly focused on what is the next round of broader workforce solutions to help me sustainably build a workforce in the -- for the coming years.
所以是的,我們仍聚焦於此;而他們也越來越聚焦於下一輪、更廣泛的人力解決方案,來協助我在未來幾年可持續地建立人力隊伍。
Operator
Operator
Joanna Gajuk, Bank of America.
Joanna Gajuk,美國銀行(Bank of America)。
Joanna Gajuk - Analyst
Joanna Gajuk - Analyst
So I guess maybe a little bit on the last comment. And I remember on the call, on the third quarter call, you were talking about you seeing some hospitals actually coming back and like offering higher rate to be able to fill some of [staff], have you seen more of it, less of it or the same? Or how is that dynamic going on?
那我想接續你剛才最後的評論再問一下。我記得在第三季電話會議上,你提到你看到有些醫院其實又回頭、像是提供更高的費率以便補足一些 [staff];你看到這種情況變多、變少,還是差不多?或者這個動態目前如何?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
We will see, particularly as the need for some of those clinicians get higher, you will see systems go back and adjust bill rates to be able to fill those orders. I don't know if at this point, we've seen a significant uptick than what we were seeing at the end of the year.
我們會看到,特別是當對某些臨床人員的需求升高時,醫療體系會回頭調整計費費率(bill rates),以便填補那些訂單。我不確定到目前為止,我們是否看到相較於年底時有顯著的上升。
But given some of my earlier commentary about the increase in unfilled orders, you would look for more systems increasing their bill rates to get some of those orders crossed is one sign of just continuing stabilizing demand over the next quarter or two.
但考量我先前提到未填補訂單增加的情況,你會預期有更多醫療體系提高其計費費率來讓部分訂單成交(crossed),這會是未來一到兩季需求持續穩定的一個訊號。
Joanna Gajuk - Analyst
Joanna Gajuk - Analyst
Okay. Another follow-up on the comment about the Q1 versus Q2, like the moving pieces, and I appreciate the strike revenue and such. But then when we think about -- and there's obviously seasonality, [that's what I'm headed] with this EBITDA margin for Q1 guidance, because I guess, last quarter, you were kind of talking about maybe like 8.5% EBITDA margin in Q1 and grow from there.
好的。再追問一個關於第一季相對第二季的評論,也就是那些變動因素;我也理解罷工收入等因素。但當我們思考——而且顯然有季節性——我想問的是第一季指引的 EBITDA 利潤率,因為我記得上季你們有提到第一季可能大約 8.5% 的 EBITDA 利潤率,之後再往上成長。
So now I guess you're guiding to a lower margin despite the fact that there is some strike revenue in there, in EBITDA. So is that sort of 8% a better starting point [in] how we should think about kind of as the year goes on how this EBITDA margin should be moving, assuming there's just normal seasonality?
所以現在我想你們是在指引較低的利潤率,儘管其中包含一些罷工收入、也會反映在 EBITDA 裡。那麼,8% 是否是更好的起點,讓我們用來思考今年接下來 EBITDA 利潤率應如何變動(假設只是正常季節性)?
Brian Scott - Chief Financial Officer & Chief Operating Officer
Brian Scott - Chief Financial Officer & Chief Operating Officer
Sure. Yes. Thanks. I think that well said as far as Q1, I think that is a good starting point in that 8%. And as we move through the year, the seasonality that we would expect to see in the second quarter, typically, nursing is down.
當然。是的。謝謝。我認為你對第一季的描述很到位;我認為以 8% 左右作為起點是合理的。而隨著我們進入今年,通常我們預期在第二季會出現季節性:護理業務通常會下滑。
Nurse and Allied are both down low single digits as we roll off winter assignments. And some of the schools impact on Allied as we get into the summer months. But we're also expecting growth in other businesses that are higher margin, like locums and our interim and search business, continued growth in language.
Nurse 與 Allied 兩者在冬季派遣(winter assignments)結束後,通常都會出現低個位數的下滑。而進入夏季月份後,學校因素也會影響 Allied。但我們也預期其他毛利率較高的業務會成長,例如 locums、我們的 interim 與 search 業務,以及語言服務的持續成長。
So those -- I think those will -- [somebody] expect them to offset each other to some degree in the second quarter, but that mix of revenue should be favorable on the gross margin as we continue to manage our G&A right now, I think that 8% is a good -- probably a good way to think about the first half of the year. And then as we move into the back half of the year as we get growth kind of across all businesses, we should see continued improvement on our gross margin and then more operating leverage, and that's where we'd start to see that EBITDA margin lift in the back half of the year.
所以這些——我認為——[某種程度上]我們預期它們在第二季會彼此抵銷一部分,但收入組合在毛利率上應該會較有利;同時我們也會持續管理目前的 G&A。我認為 8% 是一個不錯的——可能是思考上半年表現的好方式。然後當我們進入下半年,隨著各項業務都出現成長,我們應該會看到毛利率持續改善,並帶來更多營運槓桿;那時我們就會開始看到下半年 EBITDA 利潤率上升。
Joanna Gajuk - Analyst
Joanna Gajuk - Analyst
So that's another question, if I may, on the international business because I appreciate your comments around your expectations in first half and then second half. But is there any risk to this? I mean, is it sort of like things going to change come June 30 and then you can kind of be back to growing international business?
那我再問一個問題,如果可以的話,關於國際業務:我理解你對上半年與下半年的預期評論。但這裡是否有任何風險?我的意思是,是否像是到了 6 月 30 日情況就會改變,然後你們就能回到國際業務的成長?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
So we've assumed some marginal improvement of the date moving forward. It's pretty modest. So if there was no movement, there might be some kind of marginal risk towards the back end of the year, smaller relative to what we've seen either in 2024 or what we expect in the first half. So we're giving you our outlook of what we have seen historically when you've gone through a retrogression period.
所以我們假設從那個日期往後會有一些邊際改善。幅度相當溫和。因此如果完全沒有變動,年底後段可能會有一些邊際風險;相較於我們在 2024 年看到的、或我們預期上半年會看到的影響,這個風險較小。所以我們提供的是:依據歷史經驗,當你經歷一段名額倒退(retrogression)期間時,我們所觀察到的展望。
Brian Scott - Chief Financial Officer & Chief Operating Officer
Brian Scott - Chief Financial Officer & Chief Operating Officer
Yes. So there's unlikely to be upside in '25. But again, we've got this pipeline that continues to build. So it's really just a function of timing. If we don't -- the dates move forward a little bit, that it won't have a meaningful impact on this year, but it will just accelerate the recovery in that business as we get into '26 and beyond.
是的。所以在 2025 年不太可能有上行空間。但再說一次,我們有一條持續累積的管線。所以這真的只是時間點的問題。如果我們不——日期往後挪一點,對今年不會有實質影響,但會在我們進入 2026 年及之後,加速該業務的復甦。
Operator
Operator
Mark Marcon, Robert W. Baird.
Mark Marcon,Robert W. Baird。
Mark Marcon - Analyst
Mark Marcon - Analyst
Welcome back, Brian. Great to have you on the call. Wondering if you can talk a little bit on Technology and Workforce Solutions, what are you assuming in terms of VMS revenue for the first quarter? So it sounds like language is doing well. So I'm just trying to figure that part out.
歡迎回來,Brian。很高興你參與這通電話會議。想請你談談 Technology and Workforce Solutions,你們對第一季的 VMS 營收假設是什麼?聽起來語言服務表現不錯。所以我只是想釐清那一塊。
Brian Scott - Chief Financial Officer & Chief Operating Officer
Brian Scott - Chief Financial Officer & Chief Operating Officer
Yes, it's going to be likely a little bit under $20 million in the first quarter. So we [that] -- a little under $20 million in the first quarter. So we've -- as we talked about, just with some of the client transitions, the timing of the way they end up rolling off is sometimes a little bit difficult to predict. So it actually took a little bit longer in the fourth quarter. It was actually a little bit of an upside for us in Q4.
是的,第一季很可能會略低於 2,000 萬美元。所以我們——第一季略低於 2,000 萬美元。所以我們——如同我們談到的,因為一些客戶轉換,最終退場的時間點有時候有點難以預測。所以第四季其實花了更久一點。對我們來說,Q4 其實是有一點上行。
But as that settles out, that's where you're seeing one more step down in the first quarter as well as some volume declines as utilization has come down some. At this point, what we're seeing is that, that should be kind of the low watermark.
但隨著這些逐步落定,你會看到第一季再往下走一步,同時因為使用率有所下滑,量也會下降一些。就目前我們看到的情況,這應該會是相對的低點。
We've had some more recent client wins with ShiftWise Flex as those are getting implemented. And we stabilized with our current client base and then start to see some of these wins roll into '25, within Q1 should be the low point and then the team is doing everything they can to execute to start to see that grow as we move through the year.
我們最近也透過 ShiftWise Flex 拿下了一些新客戶,這些正在導入中。而且我們在現有客戶基礎上已經穩定下來,接著會開始看到這些勝利在 2025 年逐步貢獻;第一季應該會是低點,然後團隊正盡一切努力執行,隨著我們走過今年,開始看到成長。
Mark Marcon - Analyst
Mark Marcon - Analyst
Okay. And just in general, aside from the ShiftWise transition, just in terms of just what you're seeing in terms of overall volumes across the MSP as well as the elements that you're not filling, how is that trending?
了解。那整體來說,撇開 ShiftWise 的轉換不談,就你們看到的 MSP 整體量,以及你們沒有填補到的那些要素,趨勢如何?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
So if we look at kind of overall demand -- and I would say this is true both in MSP, for us, the shape of that looks a little bit different post COVID because we had focused all of our supply into that market during COVID.
如果我們看整體需求——我會說這在 MSP 也是如此——對我們而言,COVID 之後的形狀看起來有點不同,因為在 COVID 期間我們把所有供給都集中到那個市場。
So when you look at our MSP volumes, they were naturally going to go down because our starting point was so high there. Everything that we've been doing, Mark, that Brian talked about earlier to position ourselves in the non-MSP space has really been an opportunity for us. And so right now, as we look in our nurse business, and looked at the mix of where we're seeing demand. Overall, about 20% of our demand is coming from MSP and about 80% would be coming from non-MSP.
所以當你看我們的 MSP 量,它自然會下降,因為我們當時的起點非常高。Mark,我們一直在做的事情——Brian 先前提到的——是讓我們在非 MSP 領域做好定位,這對我們來說其實是個機會。因此現在,當我們看護理業務,以及我們看到需求的組合。整體而言,大約 20% 的需求來自 MSP,約 80% 來自非 MSP。
And so it was incredibly important for us over the past two years to really reposition ourselves against that broader market because we see a lot of incremental demand opportunities for us that we have been taking advantage of. So we're seeing similar trends around overall demand increasing in the nurse space since last April. We've seen very healthy demand in Allied particularly as we started 2025 and similar for locum.
因此,過去兩年對我們來說非常重要的是,真正針對更廣泛的市場重新定位,因為我們看到很多增量需求機會,而我們也一直在把握。所以我們看到護理領域的整體需求自去年四月以來呈現類似的上升趨勢。我們在 Allied(醫療輔助專業)方面看到非常健康的需求,特別是在 2025 年初;locum(代班醫師)也類似。
Mark Marcon - Analyst
Mark Marcon - Analyst
Great. And then kind of a broader industry question. There's been some obvious signs of consolidation in terms of [ECRN and AIA]. There's also been reports of some other companies in the space that might be looking for partners and seems like it would be natural to see a little bit of a shakeout and a little bit of consolidation, just given what's happened to the overall demand level since 2020.
很好。接著是一個較廣泛的產業問題。在[ECRN 和 AIA] 方面,顯然出現了一些整併的跡象。也有報導指出,這個領域裡其他一些公司可能在尋找合作夥伴;考量自 2020 年以來整體需求水準的變化,看起來自然會出現一些洗牌與整併。
And I was wondering if you could provide any commentary on what -- in terms of what you're seeing from a competitive dynamic perspective, both in terms of demand from hospitals and your competitive position and how that translates to pricing. But also in terms of are the clinicians appreciating your relative strength? And what are you seeing from that perspective?
我想請你就你們看到的競爭動態提供一些評論——包括醫院端的需求、你們的競爭地位,以及這如何反映到定價。另外,臨床人員是否也在認可你們相對的實力?你們從這個角度看到什麼?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Yes. What I would say broadly about the competitive environment, and we draw different competitors depending on what solution you're talking about. But I would say there is consistently very strong competition across the space.
是的。我會廣泛地說,競爭環境方面,取決於你談的是哪一種解決方案,我們會遇到不同的競爭對手。但我會說,整個領域一直都有非常激烈的競爭。
If we look at, Mark, to the first part of your question about what we've seen in terms of recent consolidation, what we saw most acutely in the nursing space coming out of COVID is you really had excess competitive capacity that had been built when that TAM became so significant during COVID. And you started to see both between the recent acquisition announcement, but also even some players exiting the face or getting out of it.
Mark,如果回到你問題的第一部分,關於近期整併我們看到什麼:在 COVID 之後,護理領域最明顯的是,當 COVID 期間 TAM 變得非常龐大時,市場建立了過剩的競爭產能。你開始看到不只是近期的收購公告,還有一些業者退出這個領域或離場。
I think you've really started to see some of that excess capacity start to shake out a little bit from a nursing standpoint. What we're seeing from a client perspective is particularly as clients are stepping back and saying, I really want a partner who's going to help me think about how to build a sustainable workforce for the future. The breadth and depth of our capabilities positions us very well for those conversations and to be that partner for them.
我認為你確實開始看到,從護理的角度來看,一些過剩產能正在被逐步出清。從客戶角度,我們看到的是,特別是當客戶退一步說:「我真的想要一個夥伴,幫我思考如何打造未來可持續的人力。」我們能力的廣度與深度,讓我們在這些對話中具備非常好的定位,能成為他們的夥伴。
So it's not just that we have the solutions that we have. It's that we have increasingly done a tremendous amount of work to make those solutions more integrated and more relevant to those clients. So we are seeing clients want how we are approaching the market from a total workforce standpoint.
所以不只是我們擁有哪些解決方案。而是我們也做了大量工作,讓這些解決方案更整合、對客戶更有相關性。因此我們確實看到,客戶希望我們以「整體人力(total workforce)」的角度來切入市場。
From a clinician standpoint, I'd say there's two pieces that we are seeing. One, throughout all this, and we do think there's going to continue to be consolidation in this market, not the least of which is because you really need to be able to scale your technology investments. But clinicians and clients want choice and competition.
從臨床人員角度,我會說我們看到兩件事。第一,在這一切過程中,我們確實認為這個市場會持續整併,其中一個重要原因是你必須能夠擴大規模來支撐科技投資。但臨床人員與客戶都希望有選擇與競爭。
And so from a clinician standpoint, it is also very beneficial for them to work with a player like us because we can support them in any type of role they want throughout their career. And so we are an appealing partner for them if they want to go on a contract assignment and then want to go permanent. We know them, and can help support them.
因此,從臨床人員角度來看,與我們這樣的業者合作也非常有利,因為我們可以在他們職涯中想要的任何角色上支持他們。所以如果他們想先做合約派遣,之後又想轉為正職,我們對他們有了解,也能提供支持。
Mark Marcon - Analyst
Mark Marcon - Analyst
Great. Cary, just to follow-on on that. I mean, given the consolidation, it sounds like it sounds like the competition is still tough. Or are you saying that there has been a little bit of a reduction in capacity and that your competitive position is appreciably better because of that -- because of some of the exits that have occurred.
很好。Cary,我接著追問一下。我的意思是,考量整併,你剛剛聽起來像是競爭仍然很激烈。還是你是說,產能確實有些下降,而因為一些退出,你們的競爭地位明顯變得更好?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Yes. I think it's too early for some of the exits. I think a lot of that news is much more recent. So I don't know that we've seen an impact yet of that. I'll kind of take the competition in kind of two phases.
是的。我認為就一些退出而言,現在下結論還太早。我想很多消息都相當近期。所以我不確定我們是否已經看到其影響。我會把競爭大致分成兩個階段來看。
One is we still see very significant competition around getting new clients. And so coming out of COVID, this really has been, for most parts of our business, a demand environment and getting access to that demand [locums] is a little bit different. But we really do see very strong competition there.
第一,我們仍然看到在爭取新客戶方面有非常顯著的競爭。因此在 COVID 之後,對我們大部分業務而言,這確實是一個需求導向的環境,而取得這些需求的機會——[locums] 的情況有點不同——但我們確實看到那裡的競爭非常激烈。
On the supply side, we have seen, especially with bill rates stabilizing, we have seen competitors be very rational, and they're not going to go and fill orders that are not priced appropriately or priced where it's going to be unprofitable for them, which is why we suspect we're seeing an increase in unsold order. So it's still a very competitive environment, but you have an underpinning of rational decisions that competitors are making, particularly on the supply side.
在供給端,我們看到,特別是在票據利率趨於穩定的情況下,我們看到競爭對手非常理性,他們不會去承接那些定價不合理、或定價到對他們而言會無利可圖的訂單,這也是為什麼我們懷疑未售出訂單正在增加。因此這仍然是一個競爭非常激烈的環境,但其基礎是競爭對手正在做出理性的決策,尤其是在供給端。
Operator
Operator
Jack Slevin, Jefferies.
Jack Slevin,Jefferies。
Jack Slevin - Analyst
Jack Slevin - Analyst
A lot of [mine] have been asked already, so maybe a pretty quick one. You gave some color around the margin impacts from the labor disruption revenue when you guided 4Q. Apologies if I missed it, but could you just help me see if we can frame that out in terms of gross margin and adjusted EBITDA in the 1Q guide?
我很多(問題)已經被問過了,所以我可能問一個很快的。你們在提供第四季指引時,對於勞動力中斷帶來的營收對毛利的影響提供了一些說明。如果我漏聽了先說聲抱歉,但你們能否協助我,看看能否在第一季指引中,從毛利率與調整後 EBITDA 的角度把這部分框出來?
Brian Scott - Chief Financial Officer & Chief Operating Officer
Brian Scott - Chief Financial Officer & Chief Operating Officer
As it relates to the labor disruption?
你是指與勞動力中斷相關的部分嗎?
Jack Slevin - Analyst
Jack Slevin - Analyst
That's right.
沒錯。
Brian Scott - Chief Financial Officer & Chief Operating Officer
Brian Scott - Chief Financial Officer & Chief Operating Officer
I mean there's not -- it doesn't -- I mean there's not a material difference in the margin on the labor disruption revenue. So it's really -- we're getting the flow through, obviously, through the EBITDA, but particularly as it relates to gross margin, it's not really a notable impact on Q4 or Q1.
我的意思是,沒有——它不——我的意思是,勞動力中斷營收的毛利率並沒有實質差異。所以其實——我們當然會看到它在 EBITDA 上的流入效應,但特別就毛利率而言,無論是第四季或第一季,都不是一個顯著的影響。
The bigger influences are around either mix changes within the segments or between the segments on a consolidated basis, some headwind from the international client that does have a higher margin. And then on Q4, we mentioned the sales reserve adjustment. Those are the bigger influence.
更大的影響因素在於各事業部內部或事業部之間的組合變化(mix),以合併口徑來看也是如此;另外還有來自一位國際客戶的逆風,該客戶的毛利率較高。然後在第四季,我們提到過銷售準備金(sales reserve)的調整。這些才是更大的影響因素。
Strike itself, the labor disruption events have been -- they're pretty similar in the margin. And it's just -- it's just adding revenue and and a flow-through of EBITDA. The outperformance in the fourth quarter EBITDA was -- that was the largest part of it. It was also that we had better performance in a couple of other businesses, including our VMS business and in our interim business, some areas that flow through with high margin, but that it wasn't labor disruption itself that had a big influence on the gross margin.
至於罷工本身、這些勞動力中斷事件——它們的毛利率其實相當接近。而且它只是——只是增加營收,並帶來 EBITDA 的流入。第四季 EBITDA 的超預期表現——其中最大的一部分就是這個。另外,我們在其他幾個業務也有更好的表現,包括我們的 VMS 業務以及臨時(interim)業務,有些領域能以較高毛利率流入,但並不是勞動力中斷本身對毛利率造成了很大的影響。
Jack Slevin - Analyst
Jack Slevin - Analyst
Okay. Got it. Really appreciate it. That's helpful. One quick follow-up.
好的。了解。非常感謝。這很有幫助。我再追問一個很快的問題。
I guess just taking the business at face value where you sit in the first quarter. I was hoping you could give a little color maybe on how you're thinking about free cash flow conversion for free cash generation. I guess I'm just trying to square, you had some of the benefit in Q4 that probably reverses, but on a normalized basis, sort of how we should think about converting cash going forward?
我想就以你們第一季目前所處的業務狀況來看。我希望你們能提供一些看法,談談你們如何看待自由現金流轉換率(free cash flow conversion)或自由現金流的產生。我想我是在試著對齊:你們第四季可能有一些好處在第一季會反轉,但在常態化的基礎上,我們應該如何看待未來的現金轉換?
Brian Scott - Chief Financial Officer & Chief Operating Officer
Brian Scott - Chief Financial Officer & Chief Operating Officer
Yes. I mean I think we've typically talked that the free cash flow conversion in the kind of 60s range. I would still use that as a good marker. We have adjusted our CapEx this year to reflect the current environment and revenue and expected EBITDA. So that, I think, is still a good market to use for any modeling.
是的。我的意思是,我們通常談到自由現金流轉換率大概在 60% 多的區間。我仍然會把這個當作一個很好的參考指標。我們今年已調整資本支出(CapEx),以反映目前的環境、營收以及預期的 EBITDA。所以我認為,對任何模型推估而言,這仍是一個很好的指標可用。
Does that help?
這樣有幫助嗎?
Jack Slevin - Analyst
Jack Slevin - Analyst
That's great. Yes.
非常好。是的。
Operator
Operator
Trevor Romeo, William Blair.
Trevor Romeo,William Blair。
Trevor Romeo - Analyst
Trevor Romeo - Analyst
Welcome back to Brian. Really good to have you back on these calls. Just a couple of quick ones left for me. I think, one, we talked about order volumes already a bit, but I was wondering if you could talk about your traveler on assignment volumes and maybe how they trended on a monthly basis. I think last quarter, you had some positive momentum maybe in September. So just wondering how maybe the last 4 months have gone from a TOA perspective?
歡迎 Brian 回來。很高興你回到這些電話會議上。我這邊只剩幾個很快的問題。我想第一個,我們已經稍微談過訂單量,但我想請你談談你們在派遣中的旅護(traveler on assignment,TOA)量,以及它們在月度基礎上的走勢。我記得上季你們在九月可能有一些正向動能。所以想了解一下,從 TOA 的角度看,過去 4 個月大概是怎麼走的?
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Yes. If you kind of pick up from where we had talked about before and if I looked at total travelers for Nurse and Allied, the one headwind that I would say, which is reflective of some of the comments that we talked about with international is you do see a headwind in the nursing business of international travelers coming off.
是的。如果你從我們之前談到的地方接續來看,並且我看護理與醫療輔助(Nurse and Allied)的總旅護人數,我會說有一個逆風,這也反映了我們談到國際業務的一些評論:你確實會看到護理業務中,國際旅護人數在下降所帶來的逆風。
What you would have seen as we ended the year, as you would have seen a slight increase in total travelers. And then as you go over into the first quarter, you would see, I'd say, a slight decrease when you look at winter orders, typically, 2/3 of the winter orders are in Q4, with about one-third in Q1. And so there's a (inaudible) to that.
你會看到的是,在年底時總旅護人數小幅增加。然後進入第一季時,你會看到我會說是小幅下降;因為從冬季訂單來看,通常冬季訂單的 2/3 在第四季,約 1/3 在第一季。因此這裡面有(聽不清)因素。
Trevor Romeo - Analyst
Trevor Romeo - Analyst
Got it. That's helpful. And then just one other quick one. I was wondering what kind of demand you're seeing in your school staffing business. I think that's an area we've kind of heard some positive trends from others recently I think there's been a couple of acquisitions in that area lately. So just wondering if you could give a bit more color on what you're seeing there.
了解。這很有幫助。然後我還有另一個很快的問題。我想請問你們在學校人力派遣(school staffing)業務看到的需求如何。我認為這是我們最近從其他公司聽到一些正向趨勢的領域,而且我想最近那個領域也有幾筆併購。所以想請你多提供一些你們在那邊看到的情況。
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Yes. We love the schools business, and we're off to a good start in 2025. We had some headwinds in 2024. There were some budget cuts kind of coming out of COVID that affected some of the districts and the schools that we supported and some consolidation of programs at a district level that affected a couple of clients. But if we look at 2025 and how we're starting in terms of upcoming bookings, we're off to a good start.
是的。我們很喜歡學校業務,而且我們在 2025 年有一個好的開局。我們在 2024 年遇到一些逆風。有一些從 COVID 之後延伸出的預算削減,影響了我們所支援的一些學區與學校;另外在學區層級也有一些方案整併,影響了幾個客戶。但如果我們看 2025 年,以及我們在即將到來的預訂(bookings)方面的起步情況,我們開局不錯。
Brian Scott - Chief Financial Officer & Chief Operating Officer
Brian Scott - Chief Financial Officer & Chief Operating Officer
Yes, it's always a business [where you're] -- the booking activity we're in now is impacting the fall of this year. And so as we look at our recent booking trends, we're running ahead of this time last year.
是的,這一直是一個(你會看到)——我們現在進行的預訂活動,會影響到今年秋季。因此,當我們看近期的預訂趨勢時,我們的表現領先於去年同期。
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Yes.
是的。
Brian Scott - Chief Financial Officer & Chief Operating Officer
Brian Scott - Chief Financial Officer & Chief Operating Officer
So that gives us a good degree of confidence that as we get into the '25 fall school year, our volume is expected to be higher than it was in the '24 school year.
所以這讓我們相當有信心,當我們進入 2025 年秋季學年時,我們的量預期會高於 2024 年學年。
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
And the other part, Trevor, that I would say is we introduced Televate which is a great technology for us to be able to do virtual support. And so that has gone over very well. especially as we started the bookings for the upcoming school year.
另外一點,Trevor,我想說的是,我們推出了 Televate,這是一項很棒的技術,讓我們能夠提供虛擬支援。而且它的反應非常好,特別是在我們開始為即將到來的學年進行預訂時。
Operator
Operator
Ladies and gentlemen, I'm showing no further questions in the queue. I would now like to turn the call back over to Cary for closing remarks.
各位女士先生,我這邊顯示隊列中已沒有其他問題。現在我想把電話交回給 Cary 作結語。
Cary Grace - President, Chief Executive Officer, Director
Cary Grace - President, Chief Executive Officer, Director
Great. Thank you. We appreciate your continued interest in AMN Healthcare, and I want to have a special thank you to all of our corporate and clinical employees who work hard every day to enable patient care. Thank you.
很好。謝謝。感謝各位持續關注 AMN Healthcare,我也要特別感謝我們所有企業端與臨床端的員工,他們每天努力工作以促成病患照護。謝謝。
Operator
Operator
Ladies and gentlemen, that concludes today's conference call. Thank you for your participation. You may now disconnect.
各位女士先生,今天的電話會議到此結束。感謝各位的參與。您現在可以掛線。